595 Improving specificity of epigenetic therapy through combined targeting of DNA and histone methylation
Sato, T, Cesaroni, M, Jelinek, J, Issa, J.P
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Savona, M.R, Garcia-Manero, G, Roboz, G.J, Walsh, K.J, Kropf, P.L, Issa, J.P, O’Connell, C.L, Tibes, R, Yee, K.W.L, Stock, W, Lunin, S, Berdeja, J.G, Naim, S, Hao, Y, Azab, M, Kantarjian, H
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
60 - Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Savona, M.R., Garcia-Manero, G., Roboz, G.J., Walsh, K.J., Kropf, P.L., Issa, J.P., O’Connell, C.L., Tibes, R., Yee, K.W.L., Stock, W., Lunin, S., Berdeja, J.G., Naim, S., Hao, Y., Azab, M., Kantarjian, H.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Liver DNA methylation analysis in adult female C57BL/6JxFVB mice following perinatal exposure to bisphenol A
van Esterik, J.C.J., Vitins, A.P., Hodemaekers, H.M., Kamstra, J.H., Legler, J., Pennings, J.L.A., Steegenga, W.T., Lute, C., Jelinek, J., Issa, J.P.J., Dollé, M.E.T., van der Ven, L.T.M.
Published in Toxicology letters (05.01.2015)
Published in Toxicology letters (05.01.2015)
Get full text
Journal Article
Emerging therapy in arthritis: Modulation of markers of the inflammatory process
Mortarino, P.A., Goy, D.P., Abramson, D.B., Cabello, J., Bumaguin, G.E., Vitelli, E.J., Toledo, J., Sarrio, L., Pezzotto, S.M., Mardegan Issa, J.P., Cointry, G.R., Feldman, S.
Published in Microscopy research and technique (01.02.2016)
Published in Microscopy research and technique (01.02.2016)
Get full text
Journal Article
JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5
CLEYRAT, C, JELINEK, J, GIRODON, F, BOISSINOT, M, PONGE, T, HAROUSSEAU, J.-L, ISSA, J.-P, HERMOUET, S
Published in Leukemia (01.05.2010)
Published in Leukemia (01.05.2010)
Get full text
Journal Article
JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5
Cleyrat, C, Jelinek, J, Girodon, F, Boissinot, M, Ponge, T, Harousseau, J.-L, Issa, J.P, Hermouet, S
Published in Leukemia (01.05.2010)
Published in Leukemia (01.05.2010)
Get full text
Journal Article